Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites
Bioorganic & Medicinal Chemistry · 2024
DOI: 10.1016/j.bmc.2023.117553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2024. Verfasst von Audrey Belouin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bioorganic Chemistry Laboratory, Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec H2W 1R7, Canada; Department of Chemistry, Univ…. Hauptthemen laut MEDLINE: P-Selectin, E-Selectin. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, University of Ottawa.
Abstract (Originalsprache)
Neutrophil binding to vascular P- and E-selectin is the rate-limiting step in the recruitment of immune cells to sites of inflammation. Many diseases, including sickle cell anemia, post-myocardial infarction reperfusion injury, and acute respiratory distress syndrome are characterized by dysregulated inflammation. We have recently reported sialyl Lewisx analogues as potent antagonists of P- and E-selectin and demonstrated their in vivo immunosuppressive activity. A key component of these molecules is a tartrate diester that serves as an acyclic tether to orient the fucoside and the galactoside moiety in the required gauche conformation for optimal binding. The next stage of our study involved attaching an extended carbon chain onto one of the esters. This chain could be utilized to tether other pharmacophores, lipids, and contrast agents in the context of enhancing pharmacological applications through the sialyl Lewisx / receptor-mediated mechanism. Herein, we report our preliminary studies to generate a small library of tartrate based sialyl Lewisx analogues bearing extended carbon chains. Anionic charged chemical entities are attached to take advantage of proximal charged amino acids in the carbohydrate recognition domain of the selectin receptors. Starting with a common azido intermediate, synthesized using copper-catalyzed Huisgen 1,3-dipolar cycloadditions, these molecules demonstrate E- and P-selectin binding properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioorganic Chemistry Laboratory, Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec H2W 1R7, Canada; Department of Chemistry, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada.
- Bioorganic Chemistry Laboratory, Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec H2W 1R7, Canada.
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario K1N 6N5, Canada. Electronic address: mnemer@uottawa.ca.
- Bioorganic Chemistry Laboratory, Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec H2W 1R7, Canada; Department of Chemistry, Université de Montréal, Montréal, Québec H3C 3J7, Canada; Department of Bi…
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
- University of Ottawa
- Canadian Glycomics Network
- Canadian Institutes of Health Research
Zitieren
APA
Belouin, A., Simard, R. D., Joyal, M., Maharsy, W., Lau, A., Prévost, M., Nemer, M., & Guindon, Y. (2024). Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2023.117553
Vancouver
Belouin A, Simard RD, Joyal M, Maharsy W, Lau A, Prévost M, et al. Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites. Bioorganic & Medicinal Chemistry. 2024. doi:10.1016/j.bmc.2023.117553
BibTeX
@article{Belouin2024,
author = {Belouin, Audrey and Simard, Ryan D and Joyal, Mathieu and Maharsy, Wael and Lau, Alice and Prévost, Michel and Nemer, Mona and Guindon, Yvan},
title = {Sialyl LewisX glycomimetics bearing an extended anionic chain targeting E- and P- selectin binding sites},
journal = {Bioorganic & Medicinal Chemistry},
year = {2024},
doi = {10.1016/j.bmc.2023.117553}
}
EUVIMED